Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco/Bengaluru no-code data pipeline platform; raised $42M+; real-time ELT from 150+ sources to cloud warehouses with zero maintenance.
Hevo Data is a no-code data pipeline and real-time ELT platform founded in 2017 and headquartered in San Francisco, California, with core engineering in Bengaluru, India. The company was founded by Manish Jethani and Sourabh Agarwal to provide a simpler alternative to complex, code-heavy data pipeline tools for data teams that do not have dedicated data engineering resources. Hevo's platform enables analysts and non-engineers to connect data sources, define transformations using a visual interface or Python, and load data into cloud data warehouses without writing connector code or managing pipeline infrastructure.\n\nHevo raised $42 million in funding from investors including Sequoia Capital India, Qualgro, and Unusual Ventures. The platform supports more than 150 data sources including databases, SaaS applications, advertising platforms, payment processors, and custom webhooks. Its real-time data pipeline engine processes and delivers data with sub-minute latency for streaming sources, making it suitable for analytics use cases that require near-real-time freshness. Hevo's automatic schema management handles changes in source schemas without pipeline failures, addressing one of the most common maintenance burdens for data teams.\n\nHevo positions itself as a cost-effective alternative to Fivetran and Stitch for mid-market companies and growing data teams that need broader connector coverage at lower price points. The platform's transformation capabilities include a visual mapping interface for simple field transformations, a Python transformer for complex data manipulation, and dbt integration for warehouse-native transformations. Hevo is particularly popular in the Asia-Pacific market and among companies with significant SaaS-to-warehouse integration needs.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.